At what time of day is NT‑proBNP (N‑terminal pro B‑type natriuretic peptide) concentration lowest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

NT-proBNP Levels Show No Clinically Significant Circadian Variation

NT-proBNP can be measured at any time of day without concern for circadian variation, as plasma levels remain stable throughout the 24-hour period. 1

Evidence for Timing of NT-proBNP Measurement

The available research directly addressing diurnal variation demonstrates that NT-proBNP concentrations (ranging from 782 to 934 pmol/L in the studied cohort) showed no significant circadian variability over 24 hours in patients with severe heart failure 1. This is in contrast to other biomarkers like big endothelin, which demonstrated a morning peak with systematic increases during bed rest.

Clinical Implications

  • No standardized timing required: Blood samples for NT-proBNP can be drawn at any time during the day without affecting clinical interpretation 1
  • Practical advantage: This stability makes NT-proBNP particularly useful in acute care settings where timing flexibility is essential
  • Contrast with other biomarkers: Unlike hormones with known circadian rhythms (cortisol, catecholamines) or even big endothelin, NT-proBNP does not require standardized collection conditions for time of day

Important Context from Guidelines

While the ESC guidelines 2 extensively discuss preanalytical variables affecting NT-proBNP measurement—including sample stability, specimen type, and storage conditions—they do not specify any time-of-day requirements for blood sampling. The guidelines emphasize that "in acute cardiac care situations, blood sampling conditions are less important" and focus instead on specimen handling and analytical factors.

The high intra-individual biological variability of NT-proBNP (30-50%) 2 far exceeds any potential time-of-day variation, meaning that only changes >30% should be considered clinically relevant regardless of when samples are drawn.

Related Questions

What is the normal NT‑proBNP range and how should an elevated NT‑proBNP be evaluated and managed in a 40‑year‑old adult?
What is the significance of an NT‑proBNP level of 353 pg/mL and what evaluation and management steps should be taken?
What is the normal day‑to‑day variation of NT‑proBNP levels in a stable patient?
In a patient with heart failure on a G‑tube who presents with a cough, how should a NT‑proBNP level of 173 pg/mL be interpreted and what management steps are recommended?
What is the best indicator for diagnosing heart failure: brain natriuretic peptide (BNP) or echocardiogram (echo)?
What is the recommended evaluation and initial management for a child presenting with pallor and blasts on peripheral blood smear?
What is the recommended management for a renal artery aneurysm that is stable on magnetic resonance angiography?
How should I manage an outpatient with mild hyperkalemia (serum potassium ~5.1 mmol/L) and when should I re‑check the potassium level?
How should I manage a patient who has reached their target weight while being treated with a glucagon‑like peptide‑1 (GLP‑1) receptor agonist?
What is the appropriate EHR documentation and treatment plan for a patient with a 1 cm pruritic, erythematous insect bite on the volar right forearm, with no drug allergies or relevant past medical history?
Why is the transfusion target hemoglobin set at 6 g/dL (≈60 g/L) in a hemodynamically stable child with newly diagnosed acute leukemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.